ATE146178T1 - Neuroleptisch 2-substituierte perhydro-1h- pyrido(1,2-a>pyrazine - Google Patents

Neuroleptisch 2-substituierte perhydro-1h- pyrido(1,2-a>pyrazine

Info

Publication number
ATE146178T1
ATE146178T1 AT92918074T AT92918074T ATE146178T1 AT E146178 T1 ATE146178 T1 AT E146178T1 AT 92918074 T AT92918074 T AT 92918074T AT 92918074 T AT92918074 T AT 92918074T AT E146178 T1 ATE146178 T1 AT E146178T1
Authority
AT
Austria
Prior art keywords
pct
neuroleptic
pyrido
pyrazine
substituted perhydro
Prior art date
Application number
AT92918074T
Other languages
English (en)
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE146178T1 publication Critical patent/ATE146178T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT92918074T 1991-09-25 1992-08-14 Neuroleptisch 2-substituierte perhydro-1h- pyrido(1,2-a>pyrazine ATE146178T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25

Publications (1)

Publication Number Publication Date
ATE146178T1 true ATE146178T1 (de) 1996-12-15

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92918074T ATE146178T1 (de) 1991-09-25 1992-08-14 Neuroleptisch 2-substituierte perhydro-1h- pyrido(1,2-a>pyrazine

Country Status (25)

Country Link
US (1) US5565453A (de)
EP (1) EP0607163B1 (de)
JP (1) JPH08827B2 (de)
CN (1) CN1071167A (de)
AT (1) ATE146178T1 (de)
AU (1) AU655071B2 (de)
BR (1) BR9206541A (de)
CA (1) CA2118936A1 (de)
CZ (1) CZ281775B6 (de)
DE (1) DE69215886T2 (de)
DK (1) DK0607163T3 (de)
ES (1) ES2096099T3 (de)
FI (1) FI941377A0 (de)
GR (1) GR3022483T3 (de)
HU (1) HUT71488A (de)
IL (1) IL103204A (de)
MX (1) MX9205385A (de)
MY (1) MY108303A (de)
NO (1) NO941084D0 (de)
NZ (1) NZ244473A (de)
PL (1) PL170889B1 (de)
PT (1) PT100891A (de)
TW (1) TW215090B (de)
WO (1) WO1993006101A1 (de)
ZA (1) ZA927306B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
WO1996010571A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
JP3910627B2 (ja) * 2003-03-12 2007-04-25 ファイザー・プロダクツ・インク ピリジルオキシメチルおよびベンゾイソオキサゾールのアザビシクロ環の誘導体
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CA2889249C (en) * 2012-12-20 2021-02-16 Francois Paul Bischoff Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators
AU2014206834B2 (en) 2013-01-17 2017-06-22 Janssen Pharmaceutica Nv Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
PT100891A (pt) 1993-10-29
CA2118936A1 (en) 1993-04-01
NO941084L (no) 1994-03-24
IL103204A0 (en) 1993-02-21
EP0607163A1 (de) 1994-07-27
GR3022483T3 (en) 1997-05-31
AU2460992A (en) 1993-04-27
HUT71488A (en) 1995-11-28
NZ244473A (en) 1995-04-27
JPH08827B2 (ja) 1996-01-10
HU9400851D0 (en) 1994-06-28
DE69215886D1 (de) 1997-01-23
JPH06506701A (ja) 1994-07-28
NO941084D0 (no) 1994-03-24
AU655071B2 (en) 1994-12-01
ES2096099T3 (es) 1997-03-01
WO1993006101A1 (en) 1993-04-01
DE69215886T2 (de) 1997-04-03
TW215090B (de) 1993-10-21
PL170889B1 (pl) 1997-02-28
ZA927306B (en) 1994-03-24
BR9206541A (pt) 1995-04-25
MY108303A (en) 1996-09-30
CN1071167A (zh) 1993-04-21
CZ281775B6 (cs) 1997-01-15
EP0607163B1 (de) 1996-12-11
IL103204A (en) 1996-05-14
FI941377A (fi) 1994-03-24
US5565453A (en) 1996-10-15
MX9205385A (es) 1993-03-01
FI941377A0 (fi) 1994-03-24
CZ395792A3 (en) 1994-05-18
DK0607163T3 (da) 1997-03-17

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
DE69201748T2 (de) Pyrazinderivate.
SE9003476L (sv) Novel isoindole derivatives and salts thereof, process for producing the same and antitumor agent comprising the same
ES8300729A1 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
ATE146178T1 (de) Neuroleptisch 2-substituierte perhydro-1h- pyrido(1,2-a>pyrazine
MY132057A (en) Quinoxalinones, a process for their preparation and their use
IL114968A0 (en) 1,4-dihydropyridine compounds
DE69211161T2 (de) Antibiotische 7-aminonaphthazarinderivate
EP0509098A4 (en) Ataractic
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
YU104092A (sh) NEUROLEPTIČNI 2-SUPSTITUISANI PERHIDRO-1-H-PIRIDO(1,2-a) PIRAZINI
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler